GlassScriptPhysician profile
Jake H Mills
NPI 1124693031
$4,604.41
in general payments reported to CMS, 2019-2025
36 companies · $964 in 2025
The $964 reported for 2025 was more than what 82% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $296 · 2022: $913 · 2023: $1,470 · 2024: $961 · 2025: $964.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,142 · Travel and Lodging: $226 · Education: $27.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,142.20 |
| Travel and Lodging | $225.87 |
| Education | $27.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $871.86 | 2022-2025 | Interstim |
| Janssen Biotech, INC. | $566.19 | 2021-2025 | Erleada, Akeega |
| Endo USA, INC. | $356.45 | 2024-2025 | Xiaflex, Aveed |
| Pfizer INC. | $305.26 | 2022-2025 | |
| Accord Healthcare, INC. | $298.82 | 2023-2025 | |
| Endo Pharmaceuticals INC. | $286.56 | 2021-2024 | Xiaflex, Aveed |
| Abbvie INC. | $248.38 | 2021-2024 | |
| Teleflex LLC | $218.48 | 2021-2025 | Urolift |
| Bayer Healthcare Pharmaceuticals INC. | $184.48 | 2023-2025 | |
| Astellas Pharma US INC | $129.53 | 2022-2025 | Xtandi, Myrbetriq |
| Merck Sharp & Dohme LLC | $122.02 | 2022-2025 | Keytruda, Lynparza |
| Sumitomo Pharma America, INC. | $116.22 | 2023-2025 | Orgovyx, Gemtesa |
| Urogen Pharma, INC. | $93.73 | 2022-2024 | Jelmyto |
| Procept Biorobotics Corporation | $79.34 | 2024-2025 | Aquabeam System |
| Progenics Pharmaceuticals, INC. | $77.94 | 2023-2025 | Pylarify |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ferring Pharmaceuticals INC. | $70.61 | 2024-2025 | Adstiladrin |
| Coloplast Corp | $67.76 | 2022-2024 | |
| Boston Scientific Corporation | $65.98 | 2023-2024 | Rezum Generator, Lithovue |
| Tolmar Pharmaceuticals, INC. | $45.96 | 2022 | |
| Verity Pharmaceuticals INC. | $40.10 | 2025 | Trelstar |
| Antares Pharma, INC. | $37.35 | 2022-2025 | Xyosted |
| Myriad Genetic Laboratories, INC. | $36.60 | 2023 | Prolaris |
| Travere Therapeutics, INC. | $33.33 | 2021-2022 | |
| Axonics, INC. | $33.31 | 2021-2024 | Axonics |
| Tolmar, INC. | $27.15 | 2023 | |
| Calyxo, INC. | $24.39 | 2024 | Cvac Aspiration System |
| Blue Earth Diagnostics | $22.68 | 2023 | |
| Dendreon Pharmaceuticals LLC | $19.77 | 2024 | Provenge |
| Cycle Pharmaceuticals INC | $19.56 | 2025 | Venxxiva |
| Angiodynamics, INC. | $16.66 | 2025 | Nanoknife |
| Clarus Therapeutics INC. | $16.32 | 2021 | |
| Civco Medical Instruments | $15.64 | 2025 | |
| E.R. Squibb & Sons, L.L.C. | $14.98 | 2022 | |
| Telix Pharmaceuticals | $14.54 | 2022 | |
| Hollister Incorporated | $13.30 | 2023 | Infyna Chic, Vapro Pocket, Vapro |
| Stryker Corporation | $13.16 | 2024 | Fluid Management System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jake Mills listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.